1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Comprehensive Metabolic Panel: new trials by email Literature Review of Comprehensive Metabolic Panel trials Research Report on Comprehensive Metabolic Panel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer testosterone (AndroGel®) with the 5α-reductase inhibitor dutasteride - Prostate Cancer, Castration-resistant, Metastatic | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 6 | 2009-03-01 | 2015-10-30 |
Neoplasm Metastasis (1) · Prostatic Neoplasms (1)
Memorial Sloan Kettering Cancer Center (1)
United States (1)